The Immune Response to Influenza Vaccinations in Elderly Individuals

PHASE4CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Influenza
Interventions
DRUG

Vaxigrip®

To describe the humoral immune response to Vaxigrip (IM) vaccination at Day 0 (baseline) and Day 28 according to the age and frailty status at baseline (i.e. in each study group) for each Influenza strain.

Trial Locations (9)

119228

National University Hospital, Singapore

150093

THK Seniors Activity Centre @ Henderson (Satellite 93), Singapore

150118

Moral Neighbourhood Link (Bukit Merah View), Singapore

160044

THK Seniors Activity Centre @ Beo Crescent, Singapore

160105

SARAH Senior Activity Centre, Singapore

610337

THK Seniors Service @ Taman Jurong, Singapore

648886

TaRa @ Jurong Point, Jurong West Central 2, Singapore

659674

Outpatient Clinic, St Luke's Hospital, Singapore

090003

Moral Neighbourhood Link @ Telok Blangah, Singapore

All Listed Sponsors
collaborator

National University of Singapore

OTHER

collaborator

Agency for Science, Technology and Research

OTHER

collaborator

Sanofi Pasteur, a Sanofi Company

INDUSTRY

lead

National University Hospital, Singapore

OTHER

NCT03266237 - The Immune Response to Influenza Vaccinations in Elderly Individuals | Biotech Hunter | Biotech Hunter